Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125991521 | 12599152 | 1 | I | 20160506 | 20160727 | 20160727 | PER | US-DRREDDYS-DRL/USA/16/0079594 | DR REDDYS | 0.00 | F | Y | 62.60000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125991521 | 12599152 | 1 | PS | OMEPRAZOLE MAGNESIUM DELAYED RELEASE OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 50C507929 | 78878 | 20.6 | MG | CAPSULE | BID | ||||||
| 125991521 | 12599152 | 2 | C | Naproxen OTC | 2 | Unknown | 0 | ||||||||||||
| 125991521 | 12599152 | 3 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125991521 | 12599152 | 1 | Barrett's oesophagus |
| 125991521 | 12599152 | 2 | Product used for unknown indication |
| 125991521 | 12599152 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125991521 | 12599152 | Drug ineffective | |
| 125991521 | 12599152 | Medication residue present | |
| 125991521 | 12599152 | Product solubility abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |